Drugs / Six percent hydroxy ethyl starch 130/0.4
Six percent hydroxy ethyl starch 130/0.4
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05223361 Comparator | Apr 2016 → Apr 2021 | heart valve disorder | Rajaie Cardiovascular Medical and Research Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Six percent hydroxy ethyl starch 130/0.4 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05223361 ↗ |
| Known as | HES | “This study aimed to compare the effects of 6% hydroxyethyl starch (HES) 130/0.4 and ringer's lactate (RL) priming solution on patients' outcomes undergoing isolated heart valve...” PMID 38105566 ↗ Dec 2023 |
| Known as | HES 130/0.4 | “This study aimed to compare the effects of 6% hydroxyethyl starch (HES) 130/0.4 and ringer's lactate (RL) priming solution on patients' outcomes undergoing isolated heart valve...” PMID 38105566 ↗ Dec 2023 |